Barclays Starts Medtronic, Inc. (MDT) at Equalweight
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/12/2026
- Oil rally pressures S&P, Nasdaq; Microsoft, Salesforce buoy Dow
- Oil prices rise 2% as attacks on Saudi Arabia overshadow Trump's diesel deal
- Will surging equity supply derail the U.S. bull market? Goldman Sachs weighs in
- Broadcom CEO says many AI investors are gamblers
- "Not buying Chipotle": Starbucks squashes blockbuster acquisition speculation
Tweet
Share
E-mailGet Alerts MDT Hot Sheet
Price: $91.68 +3.62%
Rating Summary:
24 Buy, 19 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 19 | Down: 20 | New: 46
Rating Summary:
24 Buy, 19 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 19 | Down: 20 | New: 46
Join SI Premium – FREE
Barclays analyst Matt Miksic initiates coverage on Medtronic, Inc. (NYSE: MDT) with a Equalweight rating and a price target of $95.00.
For an analyst ratings summary and ratings history on Medtronic, Inc. click here. For more ratings news on Medtronic, Inc. click here.
Shares of Medtronic, Inc. closed at $87.97 yesterday.
You May Also Be Interested In
- Medtronic Announces Preliminary Results of MiniMed Group, Inc. Exchange Offer
- Hovde Group Starts First Financial Corp. (THFF) at Outperform
- Hovde Group Starts Chemung Financial (CHMG) at Market Perform
Create E-mail Alert Related Categories
New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
